Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection

Nature作者:Michelle N. Vu2026年8月12日正文已收录本站

Funding

Research was supported by grants from NIAID of the NIH to (R01-AI153602 and R21-AI145400 to V.D.M., R24 AI120942 to S.C.W.)). A.L.R. was supported by a UTMB Institute for Human Infection and Immunity grant and the Sealy and Smith Foundation. Research was also supported by STARs Award provided by the University of Texas System and Burroughs Welcome Fund Investigators in Pathogenesis grant to V.D.M. Data Acquisition award provided by the Institute for Human Infections and Immunity at UTMB to M.N.V. Trainee funding provided by NIAID of the NIH to M.N.V. (T32-AI060549), C.S. (T32AI007526), and REA (T32AI007526). Experiments and analysis were provided by the Mass Spectrometry Facility at the University of Texas Medical Branch (https://www.utmb.edu/MSF) and is funded in part by CPRIT RP250644 (WKR). Figures were created with BioRender.com

Author information

Author notes

  1. Haitao Hu

    Present address: Institute of Microbiology, Chinese Academy of Sciences, Beijing, PR China

Authors and Affiliations

  1. Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA

    Michelle N. Vu, R. Elias Alvarado, Dorothea R. Morris, Kumari G. Lokugamage, Yiyang Zhou, Angelica L. Morgan, Yani P. Ahearn, Nicholas C. Hazell, Leah K. Estes, Alyssa M. McLeland, Craig Schindewolf, Jessica A. Plante, Jordan T. Murray, Scott C. Weaver, Haitao Hu, Kenneth S. Plante & Vineet D. Menachery

  2. Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, USA

    R. Elias Alvarado

  3. Department of Pediatrics, University of Texas Medical Branch, Galveston, TX, USA

    Dorothea R. Morris

  4. Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA

    Kumari G. Lokugamage, Yiyang Zhou, Angelica L. Morgan, Mehul S. Suthar & Vineet D. Menachery

  5. Emory Vaccine Center, Emory University, Atlanta, GA, USA

    Kumari G. Lokugamage, Yiyang Zhou, Angelica L. Morgan, Mehul S. Suthar & Vineet D. Menachery

  6. Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA

    Nicholas C. Hazell, William M. Meyers, Patricia A. Crocquet-Valdes, David H. Walker, Haitao Hu & Kenneth S. Plante

  7. Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA

    Jessica A. Plante, Scott C. Weaver, Kenneth S. Plante & Vineet D. Menachery

  8. World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA

    Jessica A. Plante & Scott C. Weaver

  9. Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA

    David H. Walker & Haitao Hu

  10. Department of Biochemistry and Microbiology, University of Texas Medical Branch, Galveston, TX, USA

    William K. Russell

  11. Department of Microbiology and Immunology, Scripps Research, La Jolla, CA, USA

    Andrew L. Routh

Authors

  1. Michelle N. Vu
  2. R. Elias Alvarado
  3. Dorothea R. Morris
  4. Kumari G. Lokugamage
  5. Yiyang Zhou
  6. Angelica L. Morgan
  7. Yani P. Ahearn
  8. Nicholas C. Hazell
  9. Leah K. Estes
  10. Alyssa M. McLeland
  11. Craig Schindewolf
  12. Jessica A. Plante
  13. William M. Meyers
  14. Jordan T. Murray
  15. Patricia A. Crocquet-Valdes
  16. Scott C. Weaver
  17. Mehul S. Suthar
  18. David H. Walker
  19. William K. Russell
  20. Andrew L. Routh
  21. Haitao Hu
  22. Kenneth S. Plante
  23. Vineet D. Menachery

Corresponding author

Correspondence to Vineet D. Menachery.

Ethics declarations

Competing interests

V.D.M. has filed a patent on the reverse genetic system and reporter SARS-CoV-2. M.N.V. and V.D.M. have filed a provisional patent on a stabilized SARS-CoV-2 spike protein. Other authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Source data

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vu, M.N., Alvarado, R.E., Morris, D.R. et al. Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection. Nat Commun (2026). https://doi.org/10.1038/s41467-026-76680-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41467-026-76680-4